Two Sigma Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,200
Closed -$617K 2074
2024
Q3
$617K Buy
9,200
+7,400
+411% +$608K 0.01% 1164
2024
Q2
$204K Sell
1,800
-11,900
-87% -$1.5M ﹤0.01% 2352
2024
Q1
$1.9M Sell
13,700
-21,700
-61% -$2.73M 0.02% 779
2023
Q4
$4.39M Sell
35,400
-1,400
-4% -$143K 0.04% 405
2023
Q3
$3.43M Buy
36,800
+9,700
+36% +$1.09M 0.04% 480
2023
Q2
$3.48M Buy
27,100
+21,500
+384% +$2.6M 0.05% 399
2023
Q1
$651K Buy
+5,600
New +$627K 0.01% 1085
2022
Q4
Sell
-3,600
Closed -$290K 2734
2022
Q3
$290K Sell
3,600
-7,800
-68% -$661K 0.01% 1603
2022
Q2
$850K Buy
+11,400
New +$1.04M 0.03% 617
2022
Q1
Sell
-2,000
Closed -$268K 2197
2021
Q4
$268K Sell
2,000
-12,400
-86% -$1.78M 0.01% 885
2021
Q3
$1.97M Buy
14,400
+6,000
+71% +$757K 0.06% 289
2021
Q2
$897K Buy
+8,400
New +$807K 0.03% 438

Other funds holding DXCM

Two Sigma Securities's DXCM Position: Q1 2026 in Review

Two Sigma Securities opened a new position in DexCom (DXCM) in Q1 2026: 3,251 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #1047 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in DXCM as recently as Q1 2025.

Two Sigma Securities first reported a position in DXCM in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Two Sigma Securities held 3,251 shares of DexCom worth $204K as of Q1 2026.
  • DexCom was a new Two Sigma Securities position in Q1 2026.
  • DexCom made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1047 holding.
  • Two Sigma Securities first reported a position in DexCom in Q3 2020 and has held it in 8 quarters since.
  • Two Sigma Securities's DexCom position peaked at $1.63M in Q2 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.